While these features of organoid culture may prove limiting for some studies (e.g., immune therapies targeting a cell-surface receptor that may become suppressed in tumoroid culture), this reductionist system enables interrogation of the functional consequences of individual TME-carcinoma interactions. The gene discussed is CD177; the disease is carcinoma.